Purchases and Sales Made in Q4 2023 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q4 2023. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-1.9K- 0.2% |
$69K - $120K
|
937K
$37.6M
|
|
|
Feb 15, 2024
Q4 2023
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-2.08K- 56.47% |
$75.7K - $131K
|
1.61K
$64.4K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.51K- 3.64% |
$91.3K - $158K
|
66.5K
$2.67M
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-4.47K- 10.48% |
$163K - $282K
|
38.2K
$1.53M
|
|
|
Feb 06, 2024
Q4 2023
|
Swiss National Bank
Zurich, V8 |
SELL
|
- |
-4.5K- 11.31% |
$164K - $284K
|
35.3K
$1.42M
|
|
|
Feb 14, 2024
Q4 2023
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-5.7K- 10.69% |
$207K - $359K
|
47.6K
$1.91M
|
|
|
Feb 14, 2024
Q4 2023
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-7.35K- 12.81% |
$267K - $463K
|
50K
$2.01M
|
|
|
Feb 13, 2024
Q4 2023
|
Envestnet Asset Management Inc
|
SELL
|
- |
-9.41K- 50.79% |
$342K - $593K
|
9.12K
$366K
|
|
|
Feb 14, 2024
Q4 2023
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-10.6K- 3.38% |
$385K - $667K
|
303K
$12.1M
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-12K- 4.8% |
$436K - $756K
|
238K
$9.56M
|
|
|
Oct 07, 2024
Q4 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-16.7K- 9.5% |
$608K - $1.05M
|
159K
$6.39M
|
|
|
Feb 12, 2024
Q4 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-16.7K- 9.5% |
$608K - $1.05M
|
159K
$6.39M
|
|
|
Feb 14, 2024
Q4 2023
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-19.2K- 15.53% |
$697K - $1.21M
|
104K
$4.18M
|
|
|
Feb 14, 2024
Q4 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-22.4K- 2.69% |
$813K - $1.41M
|
811K
$32.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-22.5K- 54.37% |
$819K - $1.42M
|
18.9K
$758K
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-23.7K- 2.19% |
$862K - $1.5M
|
1.06M
$42.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-25.7K- 1.27% |
$936K - $1.62M
|
2.01M
$80.6M
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-28.4K- 15.5% |
$1.03M - $1.79M
|
155K
$6.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-39.6K- 21.64% |
$1.44M - $2.5M
|
143K
$5.76M
|
|
|
Feb 14, 2024
Q4 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-68K- 69.37% |
$2.47M - $4.28M
|
30K
$1.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-118K- 61.48% |
$4.3M - $7.46M
|
74.1K
$2.97M
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-180K- 52.92% |
$6.55M - $11.4M
|
160K
$6.44M
|
|
|
Feb 14, 2024
Q4 2023
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-250K- 75.76% |
$9.09M - $15.8M
|
80K
$3.21M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-274K- 99.47% |
$9.97M - $17.3M
|
1.45K
$58.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-280K- 56.0% |
$10.2M - $17.6M
|
220K
$8.83M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-367K- 49.03% |
$13.3M - $23.1M
|
382K
$15.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-427K- 21.87% |
$15.5M - $26.9M
|
1.53M
$61.2M
|